The National Health Research Institutes (NHRI) yesterday said it has developed a rapid-testing kit that can screen people for SARS-CoV-2, the strain of coronavirus that causes COVID-19, while the Central Epidemic Command Center (CECC) said that such products have to be approved.
NHRI vice president Sytwu Huey-kang (司徒惠康) said that after more than a month of research, it has been shown that antibodies for SARS can also be used in the screening process for SARS-CoV-2.
The results can be produced in 10 to 15 minutes, Sytwu said.
Photo: AFP / National Institutes of Health
The NHRI is testing a number of coronaviruses to determine whether the reagent could be an exclusive test for COVID-19, he said.
The institutes next week would hold a meeting with businesses to discuss trial production of the kits, he said.
However, it is still uncertain when the kits might be ready for clinical use, he said.
Minister of Health and Welfare Chen Shih-chung (陳時中) told the CECC’s daily news briefing yesterday that the Centers for Disease Control (CDC) would have to verify the NHRI’s product, as well as others introduced by private companies abroad.
The CDC would help accelerate commercialization if they prove effective, said Chen, who also heads the CECC.
In other developments, the American Institute in Taiwan (AIT) posted on Facebook yesterday that US biotechnology company Gilead Sciences began clinical research collaboration with experts in Taiwan on potential treatment options.
The AIT did not name any drug in the post, but the company is known for developing remdesivir, a drug hoped to be a treatment for COVID-19.
“Gilead’s clinical trials in Asia are also taking place in China, Japan, S[outh] Korea, Singapore and Hong Kong. Last week, AIT and Taiwan’s Ministry of Foreign Affairs announced enhanced efforts to cooperate on addressing the spread of COVID-19. Scientific cooperation like this is one of the great examples of how we #StriveTogetherThriveTogether,” the AIT wrote.
Additional reporting by Lin Chia-nan
EUROPEAN TARGETS: The planned Munich center would support TSMC’s European customers to design high-performance, energy-efficient chips, an executive said Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s largest contract chipmaker, yesterday said that it plans to launch a new research-and-development (R&D) center in Munich, Germany, next quarter to assist customers with chip design. TSMC Europe president Paul de Bot made the announcement during a technology symposium in Amsterdam on Tuesday, the chipmaker said. The new Munich center would be the firm’s first chip designing center in Europe, it said. The chipmaker has set up a major R&D center at its base of operations in Hsinchu and plans to create a new one in the US to provide services for major US customers,
The Ministry of Transportation and Communications yesterday said that it would redesign the written portion of the driver’s license exam to make it more rigorous. “We hope that the exam can assess drivers’ understanding of traffic rules, particularly those who take the driver’s license test for the first time. In the past, drivers only needed to cram a book of test questions to pass the written exam,” Minister of Transportation and Communications Chen Shih-kai (陳世凱) told a news conference at the Taoyuan Motor Vehicle Office. “In the future, they would not be able to pass the test unless they study traffic regulations
‘A SURVIVAL QUESTION’: US officials have been urging the opposition KMT and TPP not to block defense spending, especially the special defense budget, an official said The US plans to ramp up weapons sales to Taiwan to a level exceeding US President Donald Trump’s first term as part of an effort to deter China as it intensifies military pressure on the nation, two US officials said on condition of anonymity. If US arms sales do accelerate, it could ease worries about the extent of Trump’s commitment to Taiwan. It would also add new friction to the tense US-China relationship. The officials said they expect US approvals for weapons sales to Taiwan over the next four years to surpass those in Trump’s first term, with one of them saying
BEIJING’S ‘PAWN’: ‘We, as Chinese, should never forget our roots, history, culture,’ Want Want Holdings general manager Tsai Wang-ting said at a summit in China The Mainland Affairs Council (MAC) yesterday condemned Want Want China Times Media Group (旺旺中時媒體集團) for making comments at the Cross-Strait Chinese Culture Summit that it said have damaged Taiwan’s sovereignty, adding that it would investigate if the group had colluded with China in the matter and contravened cross-strait regulations. The council issued a statement after Want Want Holdings (旺旺集團有限公司) general manager Tsai Wang-ting (蔡旺庭), the third son of the group’s founder, Tsai Eng-meng (蔡衍明), said at the summit last week that the group originated in “Chinese Taiwan,” and has developed and prospered in “the motherland.” “We, as Chinese, should never